Symposia: Outcomes Research—Lymphoid Malignancies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI) , patient-reported outcomes, Diseases, real-world evidence, Lymphoid Malignancies, Adverse Events, survivorship
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI) , patient-reported outcomes, Diseases, real-world evidence, Lymphoid Malignancies, Adverse Events, survivorship
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Hall A
(San Diego Convention Center)
Moderators:
Hira Mian, MD, McMaster University
and
Patrick Connor Johnson, MD, Massachusetts General Hospital
Disclosures:
Johnson: Seagen: Consultancy; AstraZeneca: Consultancy, Research Funding; ADC Therapeutics: Consultancy; Incyte: Consultancy, Research Funding; Abbvie: Consultancy; Medically Home: Research Funding; Bristol Myers Squibb: Consultancy.
In this session we will see practice changing after Patient-Reported Outcome Measurements (PROMs) and Real World Evidence (RWE) studies in patients with lymphoma. Disparities and comorbidities such as cardiovascular diseases may have a worse outcome in patients with lymphoma.
4:00 PM
4:15 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH